Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

No treatment fully stops excessive hair growth in women, but various methods can help manage it effectively.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

Better hair loss models needed for research.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Minoxidil, originally a blood pressure medication, is effective in treating hair loss in men and women, with different strengths recommended for each.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Understanding how acne develops in different diseases could lead to new treatments.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Higher androgen levels do not cause baldness in men.